Literature DB >> 6325883

Transactivation of a late herpes simplex virus promoter.

D Dennis, J R Smiley.   

Abstract

We have asked whether the promoter for the gene encoding the major capsid protein (VP5) of herpes simplex virus functions in uninfected mouse cells. Our experimental strategy was to first fuse the VP5 promoter to the herpes simplex virus thymidine kinase (TK) structural sequence and then to use the resulting hybrid gene to transform TK- cells to TK+. The recombinant gene transferred TK at an extremely low frequency by comparison with the wild-type TK gene, and the TK transcripts present within the resulting rare transformants initiated within the TK structural gene, rather than in the vicinity of the VP5 promoter. However, after infection with herpes simplex virus, large amounts of RNA driven from the VP5 promoter accumulated. We conclude that the VP5 promoter does not function in uninfected cells but is efficiently activated by virally coded factors, most likely one or more immediate-early proteins.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6325883      PMCID: PMC368734          DOI: 10.1128/mcb.4.3.544-551.1984

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  44 in total

1.  MUTANT STRAINS OF HERPES SIMPLEX DEFICIENT IN THYMIDINE KINASE-INDUCING ACTIVITY.

Authors:  D R DUBBS; S KIT
Journal:  Virology       Date:  1964-04       Impact factor: 3.616

2.  Separation and characterization of herpes simplex virus type 1 immediate-early mRNA's.

Authors:  R J Watson; C M Preston; J B Clements
Journal:  J Virol       Date:  1979-07       Impact factor: 5.103

3.  Construction and characterization of a recombinant plasmid encoding the gene for the thymidine kinase of Herpes simplex type 1 virus.

Authors:  L W Enquist; G F Vande Woude; M Wagner; J R Smiley; W C Summers
Journal:  Gene       Date:  1979-11       Impact factor: 3.688

4.  Sizing and mapping of early adenovirus mRNAs by gel electrophoresis of S1 endonuclease-digested hybrids.

Authors:  A J Berk; P A Sharp
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

5.  Control of herpes simplex virus type 1 mRNA synthesis in cells infected with wild-type virus or the temperature-sensitive mutant tsK.

Authors:  C M Preston
Journal:  J Virol       Date:  1979-01       Impact factor: 5.103

6.  Mapping of RNA by a modification of the Berk-Sharp procedure: the 5' termini of 15 S beta-globin mRNA precursor and mature 10 s beta-globin mRNA have identical map coordinates.

Authors:  R F Weaver; C Weissmann
Journal:  Nucleic Acids Res       Date:  1979-11-10       Impact factor: 16.971

7.  The ovalbumin gene-sequence of putative control regions.

Authors:  C Benoist; K O'Hare; R Breathnach; P Chambon
Journal:  Nucleic Acids Res       Date:  1980-01-11       Impact factor: 16.971

8.  Viral DNA synthesis is required for the efficient expression of specific herpes simplex virus type 1 mRNA species.

Authors:  L E Holland; K P Anderson; C Shipman; E K Wagner
Journal:  Virology       Date:  1980-02       Impact factor: 3.616

9.  Evidence that herpes simplex virus DNA is transcribed by cellular RNA polymerase B.

Authors:  F Costanzo; G Campadelli-Fiume; L Foa-Tomasi; E Cassai
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

10.  Characterization of herpes simplex virus type 1 RNA present in the absence of de novo protein synthesis.

Authors:  K P Anderson; R H Costa; L E Holland; E K Wagner
Journal:  J Virol       Date:  1980-04       Impact factor: 5.103

View more
  22 in total

1.  A cell-free recombination system for site-specific integration of multigenic shuttle plasmids into the herpes simplex virus type 1 genome.

Authors:  P J Gage; B Sauer; M Levine; J C Glorioso
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

2.  Functional analysis of the true late human cytomegalovirus pp28 upstream promoter: cis-acting elements and viral trans-acting proteins necessary for promoter activation.

Authors:  A S Depto; R M Stenberg
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

3.  Expression of the herpes simplex virus type 1 glycoprotein C gene requires sequences in the 5' noncoding region of the gene.

Authors:  J P Weir; P R Narayanan
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

4.  Herpes simplex virus virion stimulatory protein mRNA leader contains sequence elements which increase both virus-induced transcription and mRNA stability.

Authors:  E D Blair; C C Blair; E K Wagner
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

5.  Expression of a cellular gene cloned in herpes simplex virus: rabbit beta-globin is regulated as an early viral gene in infected fibroblasts.

Authors:  J R Smiley; C Smibert; R D Everett
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

6.  Direct correlation between a negative autoregulatory response element at the cap site of the herpes simplex virus type 1 IE175 (alpha 4) promoter and a specific binding site for the IE175 (ICP4) protein.

Authors:  M S Roberts; A Boundy; P O'Hare; M C Pizzorno; D M Ciufo; G S Hayward
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

7.  Cells that constitutively express the herpes simplex virus immediate-early protein ICP4 allow efficient activation of viral delayed-early genes in trans.

Authors:  R H Persson; S Bacchetti; J R Smiley
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

8.  Three trans-acting regulatory proteins of herpes simplex virus modulate immediate-early gene expression in a pathway involving positive and negative feedback regulation.

Authors:  P O'Hare; G S Hayward
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

9.  Identification of a herpes simplex virus function that represses late gene expression from parental viral genomes.

Authors:  P J Godowski; D M Knipe
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

10.  Simian alphaherpesviruses and their relation to the human herpes simplex viruses.

Authors:  J K Hilliard; D Black; R Eberle
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.